Compare CRGO & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRGO | MDAI |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.7M | 53.8M |
| IPO Year | 2022 | 2021 |
| Metric | CRGO | MDAI |
|---|---|---|
| Price | $1.34 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.40 | ★ $3.00 |
| AVG Volume (30 Days) | 37.9K | ★ 176.9K |
| Earning Date | 05-26-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,650,000.00 |
| Revenue This Year | $10.61 | N/A |
| Revenue Next Year | $16.85 | $23.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.14 | $1.18 |
| 52 Week High | $4.24 | $2.97 |
| Indicator | CRGO | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.71 | 51.45 |
| Support Level | $1.17 | $1.62 |
| Resistance Level | $1.43 | $1.77 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 78.85 | 71.43 |
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.